Wambolt & Associates, LLC Novartis Ag Transaction History
Wambolt & Associates, LLC
- $293 Million
- Q2 2025
A detailed history of Wambolt & Associates, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wambolt & Associates, LLC holds 25,647 shares of NVS stock, worth $3.06 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
25,647
Previous 27,021
5.08%
Holding current value
$3.06 Million
Previous $3.01 Million
3.02%
% of portfolio
1.06%
Previous 1.04%
Shares
27 transactions
Others Institutions Holding NVS
# of Institutions
1,550Shares Held
140MCall Options Held
1.69MPut Options Held
1.87M-
Dodge & Cox San Francisco, CA10.6MShares$1.27 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.08 Billion0.26% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$850 Million0.35% of portfolio
-
Morgan Stanley New York, NY7.06MShares$842 Million0.06% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $257B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...